United Therapeutics Corporation

This past Sunday was an exciting night as we held our annual Jenesis Innovative Research Awards™ and Trailblazer Awards™ ceremony. Both of these awards recognize US-based female researchers and clinicians who are breathing new life into the study of pulmonary hypertension (PH), idiopathic pulmonary fibrosis (IPF), and lung transplantation (LTx). The Innovative Research Awards were given to Dr. Jacqueline DesJardin, Dr. Katarina Zeder, and Dr. Caitlin Demarest for their efforts in advancing novel research and enhancing patient care in PH, IPF, and LTx. This year’s Trailblazer Award recipient, Dr. Marilyn Glassberg, and our Emerging Trailblazer Award recipient, Dr. Jianing Fu, were honored for driving the future of PH and LTx research. At #UnitedTherapeutics, we are inspired by each of these #WomenInPH who are making a difference through the power of research. Congratulations to our 2025 award recipients.

We’re honored to share that United Therapeutics has been Great Place to Work® Certified for the 8th consecutive year! This recognition reflects the vibrant, inclusive culture our employees help create every day. At UT, we believe in fostering a workplace where everyone feels welcomed, empowered, and inspired to make a difference. A huge thank you to our dedicated team—this achievement is yours. #GreatPlaceToWork #UnitherProud #TeamUT

United Therapeutics is excited to be onsite at the American Thoracic Society in San Francisco! New to virtual reality (VR)? Don't miss our immersive VR experience at Booth 451—explore the critical measures used to evaluate the right heart in pulmonary arterial hypertension through a dynamic, educational journey inside the diagnostic procedure. Also visit our #MedicalAffairs team for the latest scientific updates advancing #RespiratoryCare. Follow @UTHRMed on X (formerly Twitter) for updates from the conference and read our full press release here: https://bit.ly/43k9f3G #Pulmonology #PulmonaryHypertension #PulmonaryArterialHypertension #LungHealth #VRinMedicine #ATS2025

Meet Laura Hockaday Kang, part of the Tissue Engineering Team within the Organ Manufacturing Group at #UnitedTherapeutics. This small but powerful team is focused on one of the more ambitious frontiers in medicine: scaling up tissue engineering processes to cellularize organ-scale 3D-printed lung scaffolds. Laura's interest in medicine and desire to help people led her to a career in bioengineering to make a real difference in patients' lives. She believes that while individual contributions can be powerful, true breakthroughs happen when passionate minds work together. As she puts it, “by operating within our team, our impact and potential is so much greater.” At UT, she has found her place—and her people— where science meets purpose. Thank you for all you do, Laura! You make us #UTProud.

At #UnitedTherapeutics, we believe in perseverance, purpose, and pushing the boundaries of what's possible. Dr. Martine Rothblatt, our CEO, embodies that spirit—driven by love, resilience, and an unshakable vision. To learn more about Martine's incredible journey, check out the On Purpose+ interview with Zoetis CEO, Kristin Peck, at the link below. #OnPurpose

May 5th is #WorldPHDay—a day that deeply resonates with our mission at #UnitedTherapeutics. Today we come together as one #PulmonaryHypertension (PH) community to advocate for access to PH diagnosis, treatment, and care. Yet, our commitment extends far beyond a single day. Every day of the year, we remain steadfast in our mission to improve and extend the lives of people affected by PH, their families, healthcare providers and advocates. #SometimesItsPH #WeBreatheUnited #WorldPHDay2025

For #ThrowbackThursday, we’re reminiscing on our annual #TakeYourKidsToWorkDay that took place last week. From curious first graders to insightful high schoolers, young Unitherians got a behind-the-scenes look at a variety of departments—from data & analytics to regenerative medicine and everything in between. The day wasn’t just about exploration—it was also about giving back. Our families joined forces with the Activate Good team to assemble care kits and supplies for neighbors in need, making a meaningful impact together. This event left us feeling inspired by the bright minds of tomorrow. Thank you to all the parents who shared their families with us—we’re already looking forward to the next one! #UnitedTherapeutics

We’re pleased to report outstanding financial results for the first quarter of 2025. Learn more information and read our full press release here: https://bit.ly/4lSaRdl

As we celebrate Earth Day 2025 this week, we're excited to share our latest sustainable facility project, Warp-10. This mass timber pharmaceutical manufacturing facility is pushing the boundaries of what's possible in green construction. From biophilic design elements that connect our people with nature to covering almost 40 percent of our energy use with onsite renewable energy and striving toward net zero embodied carbon, Warp-10 is a testament to our commitment to sustainable innovation to better serve our patients' needs. Join us on this journey towards a brighter, greener, and healthier future for our patients, our people, and the planet! Read the full article to learn more: https://bit.ly/42pXUjx #Sustainability #GreenBuilding #NetZero #BiophilicDesign #EarthDay

Get ready, ISHLT 2025! United Therapeutics is packing our bags (and our research!) for an exciting trip to connect with the brightest minds in heart and lung transplantation. Swing by booth 410 to chat with our Medical Affairs team. They're ready to talk all things #PulmonaryHypertension and #OrganTransplant Come say hello, ask questions, and see how we’re helping move science forward. #ISHLT2025